Uncategorized
VIDEO: Speaker discusses new developments on Jetrea
NICE, France — At the Euretina meeting, Peter Stalmans, MD, PhD, discusses Jetrea ocriplasmin's higher success rate seen in recent studies. Ocriplasmin will soon be evaluated in the CIRCLE study for a new application in pre-proliferative diabetic retinopathy.